Neurobiology of Aging
Volume 31, Issue 3 , Pages 416-424 , March 2010

P50 gating deficit in Alzheimer dementia correlates to frontal neuropsychological function

  • Christine Thomas

      Affiliations

    • Centre for Psychosocial Medicine, Department of General Psychiatry, University of Heidelberg, Voßstr. 2, 69115 Heidelberg, Germany
    • Department of Geriatric Psychiatry, Centre of Psychiatry and Psychotherapy, Ev. Hospital Bielefeld-Bethel, Bethesdaweg 12, 33617 Bielefeld, Germany
    • Corresponding Author InformationCorresponding author at: Abteilung für Gerontopsychiatrie, Klinik für Psychiatrie und Psychotherapie Bethel, Evangelisches Krankenhaus Bielefeld, Bethesdaweg 12, 33617 Bielefeld, Germany. Tel.: +49 521 772 78695; fax: +49 521 772 78698.
    • ,
  • Ingo vom Berg

      Affiliations

    • Centre for Psychosocial Medicine, Department of General Psychiatry, University of Heidelberg, Voßstr. 2, 69115 Heidelberg, Germany
    • ,
  • Andre Rupp

      Affiliations

    • Section of Biomagnetism, Department of Neurology, University of Heidelberg, INF 400, 69126 Heidelberg, Germany
    • ,
  • Ulrich Seidl

      Affiliations

    • Centre for Psychosocial Medicine, Department of General Psychiatry, University of Heidelberg, Voßstr. 2, 69115 Heidelberg, Germany
    • ,
  • Johannes Schröder

      Affiliations

    • Centre for Psychosocial Medicine, Department of General Psychiatry, University of Heidelberg, Voßstr. 2, 69115 Heidelberg, Germany
    • ,
  • Daniela Roesch-Ely

      Affiliations

    • Centre for Psychosocial Medicine, Department of General Psychiatry, University of Heidelberg, Voßstr. 2, 69115 Heidelberg, Germany
    • ,
  • Stefan H. Kreisel

      Affiliations

    • Department of Geriatric Psychiatry, Centre of Psychiatry and Psychotherapy, Ev. Hospital Bielefeld-Bethel, Bethesdaweg 12, 33617 Bielefeld, Germany
    • ,
  • Christoph Mundt

      Affiliations

    • Centre for Psychosocial Medicine, Department of General Psychiatry, University of Heidelberg, Voßstr. 2, 69115 Heidelberg, Germany
    • ,
  • Matthias Weisbrod

      Affiliations

    • Centre for Psychosocial Medicine, Department of General Psychiatry, University of Heidelberg, Voßstr. 2, 69115 Heidelberg, Germany
    • Department of Psychiatry, SRH Klinikum, Karlsbad-Langensteinbach, Germany

Received 14 January 2008 ,Revised 21 April 2008 ,Accepted 1 May 2008.

References 

  1. Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psychiatry. 1993;150:1856–1861
  2. Adler LE, Olincy A, Waldo M, Harris JG, Griffith J, Stevens K, et al. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr. Bull. 1998;24:189–202
  3. Amieva H, Phillips LH, Della Sala S, Henry JD. Inhibitory functioning in Alzheimer's disease. Brain. 2004;127:949–964
  4. Baddeley AD, Baddeley HA, Bucks RS, Wilcock GK. Attentional control in Alzheimer's disease. Brain. 2001;124:1492–1508
  5. Barth S, Schonknecht P, Pantel J, Schroder J. Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery. Fortschr. Neurol. Psychiatr. 2005;73:568–576
  6. Boutros NN, Belger A. Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating. Biol. Psychiatry. 1999;45:917–922
  7. Boutros NN, Belger A, Campbell D, D'Souza C, Krystal J. Comparison of four components of sensory gating in schizophrenia and normal subjects: a preliminary report. Psychiatry Res. 1999;88:119–130
  8. Braak H, de Vos RA, Jansen EN, Bratzke H, Braak E. Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Prog. Brain Res. 1998;117:267–285
  9. Braak H, Del Tredici K, Schultz C, Braak E. Vulnerability of select neuronal types to Alzheimer's disease. Ann. NY Acad. Sci. 2000;924:53–61
  10. Bramon E, Rabe-Hesketh S, Sham P, Murray RM, Frangou S. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr. Res. 2004;70:315–329
  11. Buchanan RW, Summerfelt A, Tek C, Gold J. An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia. Schizophr. Res. 2003;59:29–33
  12. Buchwald JS, Erwin RJ, Read S, Van Lancker D, Cummings JL. Midlatency auditory evoked responses: differential abnormality of P1 in Alzheimer's disease. Electroencephalogr. Clin. Neurophysiol. 1989;74:378–384
  13. Cancelli I, Cadore IP, Merlino G, Valentinis L, Moratti U, Bergonzi P, et al. Sensory gating deficit assessed by P50/Pb middle latency event related potential in Alzheimer's disease. J. Clin. Neurophysiol. 2006;23:421–425
  14. Chao LL, Knight RT. Prefrontal deficits in attention and inhibitory control with aging. Cereb. Cortex. 1997;7:63–69
  15. Clementz BA, Geyer MA, Braff DL. Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophr. Res. 1998;30:71–80
  16. Court J, Martin-Ruiz C, Piggott M, Spurden D, Griffiths M, Perry E. Nicotinic receptor abnormalities in Alzheimer's disease. Biol. Psychiatry. 2001;49:175–184
  17. Cullum CM, Harris JG, Waldo MC, Smernoff E, Madison A, Nagamoto HT, et al. Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophr. Res. 1993;10:131–141
  18. D’Andrea MR, Nagele RG. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons. Curr. Pharm. Des. 2006;12:677–684
  19. Erickson KI, Colcombe SJ, Wadhwa R, Bherer L, Peterson MS, Scalf PE, et al. Training-induced plasticity in older adults: effects of training on hemispheric asymmetry. Neurobiol. Aging. 2007;28:272–283
  20. Ermutlu MN, Demiralp T, Karamursel S. The effects of interstimulus interval on sensory gating and on preattentive auditory memory in the oddball paradigm. Can magnitude of the sensory gating affect preattentive auditory comparison process?. Neurosci. Lett. 2007;412:1–5
  21. Erwin RJ, Turetsky BI, Moberg P, Gur RC, Gur RE. P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention. Schizophr. Res. 1998;33:157–167
  22. Fein G, Biggins C, van Dyke C. The auditory P50 response is normal in Alzheimer's disease when measured via a paired click paradigm. Electroencephalogr. Clin. Neurophysiol. 1994;92:536–545
  23. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12(3):189–198
  24. Freedman R, Olincy A, Ross RG, Waldo MC, Stevens KE, Adler LE, et al. The genetics of sensory gating deficits in schizophrenia. Curr. Psychiatry Rep. 2003;5:155–161
  25. Golob EJ, Miranda GG, Johnson JK, Starr A. Sensory cortical interactions in aging, mild cognitive impairment, and Alzheimer's disease. Neurobiol. Aging. 2001;22:755–763
  26. Golob EJ, Irimajiri R, Starr A. Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia. Brain. 2007;130:740–752
  27. Griffith JM, O’Neill JE, Petty F, Garver D, Young D, Freedman R. Nicotinic receptor desensitization and sensory gating deficits in schizophrenia. Biol. Psychiatry. 1998;44:98–106
  28. Irimajiri R, Golob EJ, Starr A. Auditory brain-stem, middle- and long-latency evoked potentials in mild cognitive impairment. Clin. Neurophysiol. 2005;116:1918–1929
  29. Jessen F, Kucharski C, Fries T, Papassotiropoulos A, Hoenig K, Maier W, et al. Sensory gating deficit expressed by a disturbed suppression of the P50 event-related potential in patients with Alzheimer's disease. Am. J. Psychiatry. 2001;158:1319–1321
  30. Kisley MA, Davalos DB, Engleman LL, Guinther PM, Davis HP. Age-related change in neural processing of time-dependent stimulus features. Brain Res. Cogn. Brain Res. 2005;25:913–925
  31. Korzyukov O, Pflieger ME, Wagner M, Bowyer SM, Rosburg T, Sundaresan K, et al. Generators of the intracranial P50 response in auditory sensory gating. Neuroimage. 2007;35:814–826
  32. Krause M, Hoffmann WE, Hajos M. Auditory sensory gating in hippocampus and reticular thalamic neurons in anesthetized rats. Biol. Psychiatry. 2003;53:244–253
  33. Levin ED, McClernon FJ, Rezvani AH. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl.). 2006;184:523–539
  34. Lucas-Meunier E, Fossier P, Baux G, Amar M. Cholinergic modulation of the cortical neuronal network. Pflugers Arch. 2003;446:17–29
  35. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944
  36. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39(9):1159–1165
  37. Namba H, Iyo M, Shinotoh H, Nagatsuka S, Fukushi K, Irie T. Preserved acetylcholinesterase activity in aged cerebral cortex. Lancet. 1998;351:881–882
  38. Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, et al. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch. Gen. Psychiatry. 2006;63:630–638
  39. Oswald WD, Fleischmann UM. Nürnberger-Alters-Inventar (NAI). Bern: Huber; 1997;
  40. Pekkonen E, Jaaskelainen IP, Kaakkola S, Ahveninen J. Cholinergic modulation of preattentive auditory processing in aging. Neuroimage. 2005;27:387–392
  41. Perry RJ, Hodges JR. Attention and executive deficits in Alzheimer's disease. A critical review. Brain. 1999;122(Pt 3):383–404
  42. Potter D, Summerfelt A, Gold J, Buchanan RW. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Schizophr. Bull. 2006;32:692–700
  43. Raemaekers M, Vink M, van den Heuvel MP, Kahn RS, Ramsey NF. Effects of aging on BOLD fMRI during prosaccades and antisaccades. J. Cogn. Neurosci. 2006;18:594–603
  44. Reitan RM. Validity of the trailmaking test as an indication of organic brain damage. Percept. Mot. Skills. 1958;8:271–276
  45. Repovs G, Baddeley A. The multi-component model of working memory: explorations in experimental cognitive psychology. Neuroscience. 2006;139:5–21
  46. Schonknecht P, Pantel J, Kruse A, Schroder J. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects. Am. J. Psychiatry. 2005;162:2071–2077
  47. Soininen HS, Karhu J, Partanen J, Paakkonen A, Jousmaki V, Hanninen T, et al Habituation of auditory N100 correlates with amygdaloid volumes and frontal functions in age-associated memory impairment. Physiol. Behav. 1995;57:927–935
  48. Wechsler D. Wechsler Memory Scale-Revised. San Antonio, TX: The Psychological Corporation; 1987;
  49. Weisser R, Weisbrod M, Roehrig M, Rupp A, Schroeder J, Scherg M. Is frontal lobe involved in the generation of auditory evoked P50?. Neuroreport. 2001;12:3303–3307

PII: S0197-4580(08)00147-4

doi: 10.1016/j.neurobiolaging.2008.05.002

Neurobiology of Aging
Volume 31, Issue 3 , Pages 416-424 , March 2010

Article Tools

* Image Usage & Resolution